Thrombotic thromboembolic complications

Related by string. thrombotic thromboembolic complications * thrombotic : thrombotic thrombocytopenic purpura TTP . anti thrombotic Lovenox . thrombotic disorders malignant neoplasm / thrombo embolic . Thromboembolic : venous thromboembolic events . thromboembolic complications / COMPLICATIONS . Complications : diabetic complications . Face Complications Possible * *

Related by context. Frequent words. (Click for all words.) 67 tumor lysis syndrome 67 hepatocellular 64 hyperparathyroidism 64 hypophosphatemia 64 lung fibrosis 63 transaminases 63 Nausea vomiting 63 proliferative diabetic retinopathy 63 nephrotoxicity 63 erythropoiesis 62 PDGFR 62 neutropenia thrombocytopenia 62 Metastases 62 vascular permeability 62 neovascular 62 bone marrow suppression 62 intratumoral 62 amyloid deposition 61 hypercalcemia 61 alanine aminotransferase 61 vWF 61 Dasatinib 61 renal insufficiency 61 paroxysmal nocturnal hemoglobinuria 61 pseudoaneurysm 61 cerebral ischemia 61 hypocalcemia 60 parathyroid 60 malignant transformation 60 hyperkalemia 60 receiving VELCADE 60 Thrombocytopenia 60 myeloid 60 vasospasm 60 bowel dysfunction 60 corticosteroid therapy 60 lymphadenopathy 60 narrow angle glaucoma 60 Natalizumab 60 Pulmonary hypertension 60 myocardial ischemia 60 hematologic toxicity 60 adrenal insufficiency 60 coagulopathy 60 mucosal healing 60 heparin induced thrombocytopenia 60 immune modulator 60 infective endocarditis 60 hirsutism 60 creatine kinase 60 colorectal carcinoma 60 fluid overload 59 central retinal vein 59 hypercholesterolaemia 59 extrapyramidal symptoms 59 hypoxemia 59 cerebrospinal fluid CSF 59 ileus 59 varices 59 hepatotoxicity 59 prolactin levels 59 neurologic symptoms 59 pathophysiologic 59 Hepatic 59 QTc prolongation 59 geographic atrophy 59 hypotensive 59 hemoptysis 59 platelet activation 59 systemically administered 59 secondary hyperparathyroidism 59 cyclooxygenase 2 59 lactic acidosis 59 extracranial 59 proinflammatory cytokines 59 methemoglobinemia 59 coagulation factors 59 TTR amyloidosis 59 metabolic acidosis 58 premalignant 58 neoplastic 58 Idiopathic 58 ultrasonographic 58 osteoblast 58 inflammatory autoimmune diseases 58 Angiotensin II 58 hypomagnesemia 58 neuroinflammation 58 erythrocyte sedimentation rate 58 parenchymal 58 catecholamine 58 diabetes insipidus 58 potentiated 58 TNF α 58 ischaemia 58 glomerular 58 hyperinsulinemia 58 Secondary endpoints included 58 endotoxemia 58 renal dysfunction 58 Asymptomatic

Back to home page